Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0T4HB
|
||||
| Former ID |
DNC014025
|
||||
| Drug Name |
Methyl icosylphosphonofluoridate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529659] | ||
| Formula |
C21H44FO2P
|
||||
| Canonical SMILES |
CCCCCCCCCCCCCCCCCCCCP(=O)(OC)F
|
||||
| InChI |
1S/C21H44FO2P/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25(22,23)24-2/h3-21H2,1-2H3
|
||||
| InChIKey |
IRQAGEYFWAZZPI-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cannabinoid receptor 1 | Target Info | Inhibitor | [529659] | |
| Fatty-acid amide hydrolase | Target Info | Inhibitor | [529659] | ||
| BioCyc Pathway | Anandamide degradation | ||||
| PANTHER Pathway | Endogenous cannabinoid signalingP05728:Anandamide degradation | ||||
| Pathway Interaction Database | N-cadherin signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.